Short Interest in Senseonics Holdings Inc (SENS) Grows By 17.5%

Senseonics Holdings Inc (NYSEAMERICAN:SENS) was the target of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 4,635,391 shares, an increase of 17.5% from the January 12th total of 3,946,300 shares. Based on an average daily volume of 667,199 shares, the days-to-cover ratio is presently 6.9 days. Currently, 9.6% of the shares of the stock are sold short.

In other Senseonics news, major shareholder Peter J. Barris sold 139,645 shares of the firm’s stock in a transaction dated Friday, December 8th. The stock was sold at an average price of $2.63, for a total value of $367,266.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 34.10% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently modified their holdings of the company. Bank of New York Mellon Corp bought a new stake in shares of Senseonics during the 3rd quarter valued at about $116,000. Perceptive Advisors LLC bought a new stake in shares of Senseonics during the 3rd quarter valued at about $160,000. Citadel Advisors LLC bought a new stake in shares of Senseonics during the 3rd quarter valued at about $194,000. Susquehanna International Group LLP bought a new stake in shares of Senseonics during the 2nd quarter valued at about $155,000. Finally, Raymond James Financial Services Advisors Inc. boosted its position in shares of Senseonics by 33.1% during the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 350,750 shares of the company’s stock valued at $1,119,000 after acquiring an additional 87,188 shares during the last quarter. Hedge funds and other institutional investors own 30.66% of the company’s stock.

Shares of Senseonics (NYSEAMERICAN SENS) traded up $0.03 on Friday, hitting $2.55. The stock had a trading volume of 501,547 shares, compared to its average volume of 533,430. The company has a market cap of $358.30 and a P/E ratio of -5.10. The company has a current ratio of 2.93, a quick ratio of 2.81 and a debt-to-equity ratio of 0.76. Senseonics has a 12-month low of $1.26 and a 12-month high of $3.67.

Separately, Canaccord Genuity reiterated a “buy” rating on shares of Senseonics in a research report on Wednesday, November 1st.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by American Banking News and is the property of of American Banking News. If you are reading this news story on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The correct version of this news story can be read at

About Senseonics

Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with's FREE daily email newsletter.

Leave a Reply